Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-01), BIMI Holdings's Beta is -3.8373.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
BIMI Holdings Beta Related Terms
BIMI Holdings Beta Historical Data
* Premium members only.
The historical data trend for BIMI Holdings's Beta can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, BIMI Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BIMI Holdings Beta vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BIMI Holdings's Beta distribution charts can be found below:
* The bar in red indicates where BIMI Holdings's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
BIMI Holdings (BIMI) has a Beta of -3.8373 as of Aug. 01, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BIMI Holdings and its competitors.
Is BIMI Holdings' Beta too high?
BIMI Holdings' current Beta is -3.8373. Overall, BIMI Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BIMI Holdings' Beta compare to RADCQ and HEWA?
BIMI Holdings' Beta of -3.8373 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BIMI Holdings and its competitors. BIMI Holdings's current Beta is -3.8373. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BIMI Holdings stock overvalued right now?
BIMI Holdings (BIMI) has a current Beta of -3.8373. The current Beta is -3.8373. BIMI Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For BIMI Holdings (BIMI), the current Beta is -3.8373 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BIMI Holdings Inc is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. It operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and OTC medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. Medical services include private comprehensive hospitals operating in China.
16GF Score
Get the complete analysis for BIMI
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIMI has been successfully added to your 
